| Thienodibenzoazulene compounds as tumor necrosis factor inhibitors -> Monitor Keywords |
|
|
  Thienodibenzoazulene compounds as tumor necrosis factor inhibitorsUSPTO Application #: 20050171091Title: Thienodibenzoazulene compounds as tumor necrosis factor inhibitors Abstract: The present invention relates to the dibenzoazulene compounds represented by formula I as well as to their pharmaceutical preparations for the inhibition of tumor necrosis factor alpha (TNF-α) and interleukine 1 (IL-1) in mammals at all diseases and conditions where these mediators are excessively secreted. The compounds of the present invention also demonstrate an analgetic action and can be used to relieve pain. (end of abstract)
Agent: Darby & Darby P.C. - New York, NY, US Inventors: Mladen Mercep, Milan Mesic, Dijana Pesic, Zeljko Zupanovic, Boska Hrvacic USPTO Applicaton #: 20050171091 - Class: 514215000 (USPTO) Related Patent Categories: Drug, Bio-affecting And Body Treating Compositions, Designated Organic Active Ingredient Containing (doai), Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai, Hetero Ring Is Seven-membered Consisting Of One Nitrogen And Six Carbons, Polycyclo Ring System Having The Seven-membered Hetero Ring As One Of The Cyclos, Additional Hetero Atom In The Polycyclo Ring System
Click on the above for other options relating to this Thienodibenzoazulene compounds as tumor necrosis factor inhibitors patent application. ###  How KEYWORD MONITOR works... a FREE service from FreshPatents1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored. 3. Each week you receive an email with patent applications related to your keywords. Start now! - Receive info on patent apps like Thienodibenzoazulene compounds as tumor necrosis factor inhibitors or other areas of interest. ### Previous Patent Application: Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases Next Patent Application: Chemical compounds Industry Class: Drug, bio-affecting and body treating compositions ### FreshPatents.com Support Thank you for viewing the Thienodibenzoazulene compounds as tumor necrosis factor inhibitors patent info. IP-related news and info Results in 0.95624 seconds Other interesting Feshpatents.com categories: Canon USA , Celera Genomics , Cephalon, Inc. , Cingular Wireless , Clorox , Colgate-Palmolive , Corning , Cymer , |
|||
